Delivery Order VA24217D0012-0002

This is a delivery order awarded by the Veterans Integrated Service Network 2 (VISN 2) of the U.S. Department of Veterans Affairs to Crescendo Bioscience, Inc., a for-profit organization, for Rheumatoid Arthritis Disease Activity Testing services. The award, with a ceiling value of $452,168.04, was made on December 19, 2016, and has a completion date of October 31, 2018. The contract is a firm fixed-price delivery order, and there was no set-aside used. This award is associated with a larger...

The Department of Veterans Affairs Veterans Integrated Service Network 22 awarded a $396,950.48 firm fixed-price purchase order to Bio-Rad Laboratories, Inc. on February 14, 2025, for immunology testing supplies supporting the VA Greater Los Angeles Healthcare System. The contract, which runs through August 13, 2026, procures brand-name Bio-Rad diagnostic reagents and testing materials for the facility's immunology testing department, with particular emphasis on Antinuclear Antibody (ANA)...

ADL Diagnostics, Inc., operating as Anavasi Diagnostics, received a $14.9 million firm fixed-price definitive contract from the National Heart, Lung, and Blood Institute (NHLBI) to develop and deliver a low-cost, moderate-throughput COVID-19 diagnostic test. The contract, awarded November 5, 2021, with a completion date of May 4, 2023, supports the RADX Tech initiative #2180, a federal program designed to rapidly scale up testing capacity for COVID-19 across community-based settings and small...

The Defense Logistics Agency awarded a $18,443.95 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 162 milligram/0.9 milliliter syringes of Actemra. Actemra is a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The place of performance for the delivery order is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The period of performance is brief, spanning just one day from September 19, 2023 through...

The Defense Health Agency awarded a Blanket Purchase Agreement (BPA) call to Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and laboratory testing supplies, on September 15, 2025. This firm fixed-price BPA call carries a ceiling value of $41,454.06 and is scheduled for completion by September 18, 2025. The award supports the automated autoimmune testing capabilities provided by Werfen USA, leveraging the company's expertise in supplying advanced...

The National Institute of Dental and Craniofacial Research awarded a $154,073 firm fixed-price purchase order to The Johns Hopkins University for rheumatologist services, with a completion date of November 27, 2026. The contract, which was awarded on November 28, 2025, carries no set-aside designation, indicating open competition. Services will be performed in Bethesda, Maryland. The underlying solicitation was issued as a Special Notice by the National Heart Lung and Blood Institute, a division...

The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on September 12, 2025, for RINVOQ ER 15 mg tablets (unit of use, 30 count) with a ceiling value of $17,167.72. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a competitively awarded, non-set-aside contract with place of performance in Conshohocken, Pennsylvania. RINVOQ (upadacitinib) is a Janus kinase inhibitor used to treat...

The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,151.60 for ACTEMRA 162 mg/0.9 mL syringes on December 17, 2025, with an ultimate completion date of December 18, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December...

The Defense Logistics Agency awarded a $2,859.85 firm fixed price delivery order to AmerisourceBergen Drug Corp for Actemra ActPen (162 mg/0.9 ml), a biologic immunosuppressant medication used primarily to treat rheumatoid arthritis and other inflammatory conditions. The contract, awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics headquartered in Hercules, California, was awarded a $22,495 firm fixed-price Blanket Purchase Agreement (BPA) call on July 8, 2020, by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The contract, with an ultimate completion date of December 31, 2020, covers a CFX96 optical reaction module for real-time polymerase chain reaction (PCR) systems, including a 96-well...